1Au WY,Lie AK,Chim CS,et al.Arsenic trioxide in comparison with chemotherapy and bone marrow transplantation for the treatment of relapsed acute promyelocytic leukemia[J].Ann Onc,2003,14:752.
2Karlsson J,ORa I,Porn-Ares I,et al.Arsenic trioxide-induced death of neuroblastoma cells involves activation of Bax and does not require p53[J].Clin Cancer Res,2004,10(9):3179.
3Kwong YL,Todd D.Delicious poison:arsenic trioxide for the treatment of leukemia[J].Blood,1997,89:3487.
4Woo SH,Park IC,Park MJ,et al.Arsenic trioxide induces apoptosis through a reactive oxygen species-dependent pathway and loss of mitochondrial membrane potential in HeLa cells[J].Int J Oncol,2002,21(1):57.
5Kang YH,Yi MJ,Kim MJ,et al.Caspase-independent cell death by arsenic trioxide in human cervical cancer cells:reactive oxygen species-mediated poly(ADP-ribose) polymerase-1 activation signals apoptosis-inducing factor release from mitochondria[J].Cancer Res,2004,64:8960.
6Uslu R,Sanli UA,Sezgin C,et al.Arsenic trioxide-mediated cytotoxicity and apoptosis in prostate and ovarian carcinoma cell lines[J].Clin Cancer Res,2000,6:4957.
7Chou WC,Hawkins AL,Barrett JF,et al.Arsenic inhibition of telomerase transcription leads to genetic instability[J].J Clin Invest,2001,108:1541.
8Zhang TC,Schmitt MT,Mumford JL.Effects of arsenic on telomerase and telomeres in relation to cell proliferation and apoptosis in human keratinocytes and leukemia cells in vitro[J].Carcinogenesis,2003,24:1811.
2Chen GQ, Zhu J, Shi XG, et al. In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As203) in the treatment of acute promyelocytic leukemia: As203 induces NB4 cellapoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins[J ]. Blood, 1996, 88(3) : 1052.
3Chen GQ, Shi XG, Tang W, et al. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL):I . As2O3 exerts dose-dependent dual effect on APL cells[J].Blood, 1997, 89(9):3345.
4Muto A, Kizaki M, Kawamura C, et al. A novel differentiationinducing therapy for acute promyelocytic leukemia with a combination of arsenic trioxide and GM-CSF[J]. Leukemia, 2001,15(8):1176.
5Du YH, Paul CH. Aresenic compounds induce cytotoxicity and apoptosis in cisplatin-sansitive and-resistant gynecological cancer cell lines[J]. Cancer Chernother Pharmacol, 2001, 47(6) :481.
6Uslu R, Sanli UA, Sezgin C, et al. Arsenic trioxide-mediated cytotoxicity and apoptosis in prostate and ovarian carcinoma celllines[J]. Clin Cancer Res, 2000,6(12):4957.
7Li YM, Brcome JD. Arsenic targets tubulins to induce apoptosis in myeloid leukemia cells[J]. Cancer Res, 1999,59(4) :776.
8McGuire WP, Hoskins WJ ,Brady MF, et al. Cyclophosphamide and eisplatin compared with paclitaxel and cisplatin in patients with stage m and stage IV ovarian cancer[J]. N Engl J Med,1996,334(1) : 1.
9Hamilton TC, Young RC, MeKoy WM, et al. Characterization of a human ovarian carcinoma cell line (NIH: OVCAR-3) with androgen and estrogen receptors[J]. Cancer Res, 1983, 43(11): 5379.
3JASPREET S S,RAFAEL A P.Cell cycle inhibition by sodium arsenite in primary embryonic rat midbrain neuroepithelial cells jaspreet[J].ToxicologicalSciences,2006,89(2):475-484.
4LANAD P.A death in life of P53[J].Nature,1993,362:786-788.
5ZHOU C X,JOHN F,VBAEJU M P.Induction of apoptosis and inhibition of telomerase activity by arsenic trioxide (As2O3) in endometrial carcinoma cells[J].Gynecologic Oncology,2007,105:218-222.
6JEMAL A,SIEGEL R.Cancer statistics[J].CA Cancer J Clin,2006,56(2):106.
7BEERAM M,PATNA I K,ROW I E.Regulation of cRaf-1:therapeutic implications[J].Clin Adv Hematol Oncol,2003,1(8):476-481.
8IWAMA K,NAKAJO S,AIUCHI T,et al.Apoptosis induced by arsenic trioxide in leukemia U937 cells is dependent on activation of p38,inactivation of ERK and the Caspase pendent production of superoxide[J].Int J Cancer,2001,92:518-526.
